Eintrag weiter verarbeiten
How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery
Gespeichert in:
| Zeitschriftentitel: | Genetic Engineering & Biotechnology News |
|---|---|
| In: | Genetic Engineering & Biotechnology News, 40, 2020, 1, S. 11-11 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Mary Ann Liebert Inc
|
| Schlagwörter: |
| spelling |
1935-472X 1937-8661 Mary Ann Liebert Inc Management of Technology and Innovation Biomedical Engineering Bioengineering Biotechnology http://dx.doi.org/10.1089/gen.40.01.03 How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery Genetic Engineering & Biotechnology News |
|---|---|
| doi_str_mv |
10.1089/gen.40.01.03 |
| facet_avail |
Online Free |
| finc_class_facet |
Wirtschaftswissenschaften Biologie Medizin Technik Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4OS9nZW4uNDAuMDEuMDM |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4OS9nZW4uNDAuMDEuMDM |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Mary Ann Liebert Inc, 2020 |
| imprint_str_mv |
Mary Ann Liebert Inc, 2020 |
| issn |
1935-472X 1937-8661 |
| issn_str_mv |
1935-472X 1937-8661 |
| language |
English |
| mega_collection |
Mary Ann Liebert Inc (CrossRef) |
| match_str |
2020howbiopharmaceuticalcompaniescanleveragestateoftheartsinglecelltechnologyforrarecelldiscovery |
| publishDateSort |
2020 |
| publisher |
Mary Ann Liebert Inc |
| recordtype |
ai |
| record_format |
ai |
| series |
Genetic Engineering & Biotechnology News |
| spellingShingle |
Genetic Engineering & Biotechnology News How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery Management of Technology and Innovation Biomedical Engineering Bioengineering Biotechnology |
| source_id |
49 |
| title |
How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_unstemmed |
How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_full |
How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_fullStr |
How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_full_unstemmed |
How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_short |
How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_sort |
how biopharmaceutical companies can leverage state of the art single cell technology for rare cell discovery |
| topic |
Management of Technology and Innovation Biomedical Engineering Bioengineering Biotechnology |
| url |
http://dx.doi.org/10.1089/gen.40.01.03 |
| publishDate |
2020 |
| physical |
11-11 |
| description |
|
| container_issue |
1 |
| container_start_page |
11 |
| container_title |
Genetic Engineering & Biotechnology News |
| container_volume |
40 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792324989215571985 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T11:58:28.696Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=How+Biopharmaceutical+Companies+Can+Leverage+State+of+the+Art+Single+Cell+Technology+for+Rare+Cell+Discovery&rft.date=2020-01-01&genre=article&issn=1937-8661&volume=40&issue=1&spage=11&epage=11&pages=11-11&jtitle=Genetic+Engineering+%26+Biotechnology+News&atitle=How+Biopharmaceutical+Companies+Can+Leverage+State+of+the+Art+Single+Cell+Technology+for+Rare+Cell+Discovery&rft_id=info%3Adoi%2F10.1089%2Fgen.40.01.03&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792324989215571985 |
| container_issue | 1 |
| container_start_page | 11 |
| container_title | Genetic Engineering & Biotechnology News |
| container_volume | 40 |
| description | |
| doi_str_mv | 10.1089/gen.40.01.03 |
| facet_avail | Online, Free |
| finc_class_facet | Wirtschaftswissenschaften, Biologie, Medizin, Technik, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4OS9nZW4uNDAuMDEuMDM |
| imprint | Mary Ann Liebert Inc, 2020 |
| imprint_str_mv | Mary Ann Liebert Inc, 2020 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1935-472X, 1937-8661 |
| issn_str_mv | 1935-472X, 1937-8661 |
| language | English |
| last_indexed | 2024-03-01T11:58:28.696Z |
| match_str | 2020howbiopharmaceuticalcompaniescanleveragestateoftheartsinglecelltechnologyforrarecelldiscovery |
| mega_collection | Mary Ann Liebert Inc (CrossRef) |
| physical | 11-11 |
| publishDate | 2020 |
| publishDateSort | 2020 |
| publisher | Mary Ann Liebert Inc |
| record_format | ai |
| recordtype | ai |
| series | Genetic Engineering & Biotechnology News |
| source_id | 49 |
| spelling | 1935-472X 1937-8661 Mary Ann Liebert Inc Management of Technology and Innovation Biomedical Engineering Bioengineering Biotechnology http://dx.doi.org/10.1089/gen.40.01.03 How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery Genetic Engineering & Biotechnology News |
| spellingShingle | Genetic Engineering & Biotechnology News, How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery, Management of Technology and Innovation, Biomedical Engineering, Bioengineering, Biotechnology |
| title | How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_full | How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_fullStr | How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_full_unstemmed | How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_short | How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| title_sort | how biopharmaceutical companies can leverage state of the art single cell technology for rare cell discovery |
| title_unstemmed | How Biopharmaceutical Companies Can Leverage State of the Art Single Cell Technology for Rare Cell Discovery |
| topic | Management of Technology and Innovation, Biomedical Engineering, Bioengineering, Biotechnology |
| url | http://dx.doi.org/10.1089/gen.40.01.03 |